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RWorsening of verbal ﬂuency after treatment with deep brain stimulation in Parkinson's disease patients is themost often reported cognitive adverse effect. The underlyingmechanisms of this decline are notwell understood.
The present focused review assesses the evidence for the reliability of the often-reported decline of verbal
ﬂuency, aswell as the evidence for the suggestedmechanisms includingdisease progression, reducedmedication
levels, electrode positions, and stimulation effect vs. surgical effects. Finally, we highlight the need for more sys-
tematic investigations of the large degree of heterogeneity in the prevalence of verbal ﬂuency worsening after
DBS, as well as provide suggestions for future research.
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C1. IntroductionThis focused review was invited as a result of the II. International
Conference on Deep Brain Stimulation (Düsseldorf, March 2016), and
it aims to provide an up-to-date status on the incidence and potential
explanations for the often-reported verbal ﬂuency (VF) decline after
deep brain stimulation (DBS) in Parkinson's disease (PD), as well as a
set of pointers for future research. Several explanations have been pro-
posed including disease progression, reduced medication levels,
microlesions, as well as electrode location and stimulation itself, but
with no clear conclusions drawn so far. Advancing our understanding
of this aspect of DBS contributes to the continued improvement of the
DBS treatment, aswell as to our understanding of the effectmechanisms
behind DBS.
The timeliness of this focused review has allowed us to include three
recently published meta-analyses on neuropsychological adverse ef-
fects (including VF worsening) after DBS in PD [12,80,81]. As revealed
by Combs et al. [12], there are relatively few studies assessing VF de-
clines after DBS in the internal globus pallidus (GPi) compared to DBS
in subthalamic nucleus (STN), which is also mirrored in this review.
This underrepresentation of GPi studies is reﬂective of a general tenden-
cy in the ﬁeld to prefer STN to GPi as target for DBS in PD [63], as well as
of potential differences in cognitive adverse effects between the two
targets [12].80
81
82
83
84
egrative Neuroscience (CFIN),
DNC, 4th ﬂoor, 8000 Aarhus C,
. on behalf of Research Network of C
orsening of Verbal Fluency Af
.doi.org/10.1016/j.csbj.2016.1The structure of this review centers around two overarching
questions:
1. What is the evidence for verbal ﬂuency (VF) worsening after DBS-
treatment in PD?
2. What are the possible mechanisms underlying such a decline?
In response to 1, we will review the evidence for the commonly re-
ported VF decline in relation to pre- and post-surgery evaluations for
both STN- and GPi-DBS, as well as highlight the large degree of hetero-
geneity in the incidence of VF worsening following DBS, which has not
been investigated systematically yet.
In response to 2, we will review the literature in relation to sug-
gested explanations such as disease progression, reduced medication
levels, electrode positions, and stimulation vs. lesion effects.
2. Background
PD is a progressive neurodegenerative disease characterized by the
motor symptoms rest tremor, postural instability, rigidity and bradyki-
nesia (slowness of movement) and a variety of non-motor symptoms
including cognitive decline and worsening of VF [53,86].
DBS in STN and GPi has been shown to effectively alleviate PD pa-
tients' motor symptoms when medication is no longer a viable treat-
ment [17,21,32,36,46,87,88]. However, the effects of DBS on cognition
are still not well understood [79]. And as already mentioned, one of
the most consistently reported detrimental effects of DBS in PD is a
worsening of VF [12,48,69,79–81]. VF deﬁcits are also part of the PD
symptomatology prior to DBS surgery [24], but the underlying cause
of the worsening after DBS is still an open question.omputational and Structural Biotechnology. This is an open access article under the CC BY
ter Deep Brain Stimulation in Parkinson's Disease: A Focused Review,
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Verbal ﬂuency is tested with a task requesting the patient, within a
minute, to nameasmanywords as possible startingwith a speciﬁc letter
(e.g., F, A, or S; known as phonemic or letter ﬂuency) or stemming from
a given category (e.g., animals; known as semantic or category ﬂuency)
[8,35]. Deﬁcits in verbalﬂuencymay thus comeabout fromboth linguis-
tic and executive dysfunctions as it involves a multitude of cognitive
processes including lexical search, memory retrieval, executive func-
tioning, response monitoring, inhibition and selection [35,59].
3. Evidence for Worsening of Verbal Fluency After DBS
When assessing the evidence for VFworsening after DBS, it is impor-
tant to note the point raised byWoods et al. [78] that far from all studies
reporting on cognitive sequelae of DBS include the sufﬁcient sample
sizes to detect even large effect sizes. In fact, in their sample of 30 pub-
lished studies, only two studies did. This urges caution in interpreting
the results of most individual studies on this topic and places a strong
emphasis on the results of carefully conducted meta-analyses, and in
the absence of such on the results fromwell-powered randomized con-
trol trial (RCT) studies.
Fortunately, in relation to the evidence for VF worsening after DBS,
two meta-analyses have aptly summed up the available literature on
pre- and post-surgery evaluations of the cognitive sequelae of DBS at
least three months after surgery.
Parsons et al. [48] conducted a meta-analysis on 28 studies from
1990 to 2006 on STN-DBS meeting inclusion criteria which included
reporting of change scores, and neuropsychological evaluations at
baseline and follow-up. Among the 28 studies, 16 reported data for pho-
nemic VF (355 patients), and 16 reported data for semantic VF (337 pa-
tients), summing up to 21 studies in total reporting on phonemic and/or
semantic VF. On the basis of this, they found average effect sizes ofmod-
erate size (0.51 and 0.73) for both phonemic and semantic VF declines.
Combs et al. [12] extended Parsons et al.'s [48] meta-analysis from
2006by analyzing studieswith baseline and follow-upneuropsycholog-
ical evaluations from both STN- and/or GPi-DBS treatments in PD. These
meta-analyses revealed that both targets resulted in moderate effect
size declines in both phonemic and semantic VF. However, the available
evidence for the effects of GPi-DBS on VF are still relatively sparse, and
therefore the observed slight disadvantage for STN is inconclusive. In
their two meta-analyses on STN-DBS and GPi-DBS, there are a few in-
consistencies. First, there are overlapping study cohorts (Ardouin et al.
[5] and Pillon et al. [50]; Daniels et al. [15] andWitt et al. [74]). Second,
the reported total number of studies included vs. those listed in the
overview table do not exactly match ([12], Table 1). And third, the
total numbers of patients reported for the phonemic VF task for both
STN-DBS and GPi-DBS exceed the total sums of included study patients
in the overview table ([12], Tables 1–3). However, these inconsistencies
are minor, and we deem the reported results credible.
There is thus reliable evidence for a worsening of moderate effect
size in both phonemic and semantic VF after STN-DBS. The evidence
for a similar decline in GPi-DBS is still too sparse to be considered reli-
able, but there are subtle tendencies suggesting a slight disadvantage
for STN (when considering other cognitive adverse effects, as well).
Following the publication of the results from the large RCT study on
STN- and GPi-DBS by the CSP-468 Study Group ([21,55,70,71], the de-
bate on which target – STN or GPi – to select for DBS in PD has received
renewed attention [42,73].
4. Suggested Causes of Worsening of Verbal Fluency
4.1. Disease Progression
In order to assess the continued disease progression as a potential
explanation of the reported VF declines, studies are needed which in-
clude a matched PD control group on best medical treatment (BMT)
with VF testing at similar baseline and follow-up intervals as the DBSPlease cite this article as: Højlund A, et al, Worsening of Verbal Fluency Af
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group. Very recently, two meta-analyses were conducted on such stud-
ies comparing VF declines in STN-DBS PD patients and in PD patients on
BMT [80,81]. Bothmeta-analyses seem to conﬁrm that PD patients after
STN-DBS treatment experience VF worsening to a larger extent
(i.e., moderate to small effect sizes) than matched PD patients on BMT.
However, these results should be interpretedwith considerable caution
due to substantial methodological issues in both meta-analyses.
First, Wyman-Chick [80] included eligible studies published be-
tween 2000 and June 2014, but only 9 out of 140 identiﬁed studies
met the study's inclusion criteria for phonemic VF and also only 9 for se-
mantic VF (i.e., in total, 10 studieswere included: 8with both phonemic
and semantic, 1with only phonemic, and 1with only semantic VF data).
Furthermore, the author relied on comparisons of the two groups' VF
scores only at the follow-up evaluation (and not the groups' change
scores). But a difference in follow-up scores is not necessarily reﬂective
of a difference in change scores. Both Marshall et al. [38] and Zangaglia
et al. [85] are examples of this discrepancy. InMarshall et al. [38] neither
phonemic nor semantic VF changes were signiﬁcantly different be-
tween the DBS-treated and BMT groups (p=0.41 and p=0.60, respec-
tively). However, when only the follow-up values were included in
Wyman-Chick's [80] meta-analysis, the differences between the two
groups were assigned adjusted effects sizes of −0.33 and −0.21 for
phonemic and semantic VF, respectively, denoting small, but substan-
tial, differences between the two groups at follow-up. Zangaglia et al.
[85] reported a signiﬁcant difference in phonemic VF scores between
the two groups at the 36-month-follow-up. However, therewas already
a noticeable difference between the two groups at the baseline, albeit
non-signiﬁcant, and the STN-DBS PD group's phonemic VF scores did
not change signiﬁcantly between baseline and follow-up (p = 0.164).
Hence, none of the included differences in follow-up VF scores from
the two studies adequately reﬂect a reduction in VF scores due to the
DBS treatment compared to BMT.
Second, Xie et al. [81] included studies published until June 2015 and
focused on potential differences in the two groups' change scores. For
the VF deﬁcits, this meant that only 6 and 4 out of 172 identiﬁed articles
were included for phonemic and semantic VF, respectively (these num-
bers are available in the article's supplementarymaterial). Unfortunate-
ly, the authors included both Witt et al. [75] and Daniels et al. [15] as
separate studies, yet these are overlapping cohorts (Witt et al. [75] ana-
lyzed a subset of the patients in Daniels et al. [15]). Furthermore, it
seems the authors selected the wrong standard deviation (SD) values
from the study by Castelli et al. [9] and Rothlind et al. [55]. They wrong-
fully interpreted the SD values of themean values at the follow-up eval-
uations as belonging directly to the change scores. Castelli et al. [9] is
also included in Wyman-Chick's [80] meta-analysis where she has
interpreted exactly the same SD values as belonging to themean values
at the follow-up evaluation. Furthermore, it is not clear why only the
phonemic (and not also semantic) VF values were included from Cilia
et al. [11], Merola et al. [40], and Rothlind et al. [55] under “Processing
speed” in Table 3), and vice-versa for the semantic (but not phonemic)
VF values from Williams et al. [72], when both sets of VF values were
readily available in all four studies. Including these values could have in-
creased the number of properly included studies for both VF scores to
six (when also accounting for the overlap between Witt et al. [75] and
Daniels et al. [15]).
Hence, bothmeta-analyses suffer from relatively low power ([81], in
particular), aswell as from substantialmethodological issues.We there-
fore consider their combined evidence relatively inconclusive.
However, if we focus on the two RCT studies included in the meta-
analyses, i.e., Witt et al. [74] and Rothlind et al. [55], they both provide
evidence in the form of well-powered direct comparisons of the change
scores of bothDBS and BMT groups. Both report signiﬁcantworsening of
both phonemic and semantic VF in the DBS groups compared to the
BMT group between baseline and after 6 months. In fact, Rothlind
et al. [55] included both an STN- and a GPi-DBS group, and both groups
showed very similar declines in VF after DBS compared to the BMTter Deep Brain Stimulation in Parkinson's Disease: A Focused Review,
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group. Hence, disease progression does not seem to be able to account
for the observed worsening of VF after DBS, regardless of target.
4.2. Reduced Dopaminergic Medication Levels
STN-DBS (but not GPi-DBS) is often followed by a signiﬁcant reduc-
tion in dopaminergicmedication [21]. Based on this general observation
as well as a correlation between greater reduction in dopaminergic
levels and greater worsening of phonemic VF in their own study,
Sáez-Cea et al. [56] suggested that reduced medication levels may play
a role in the observed VF declines. However, to the best of our knowl-
edge, only one study [22] has reported that PD patients OFF dopaminer-
gicmedication performedworse on (semantic) VF thanhealthy controls
whereas there was no signiﬁcant difference when the patients were ON
medication. This could suggest a beneﬁcial role of dopaminergic medi-
cation on VF performance (as brieﬂy mentioned by Cools [13] with ref-
erence to Gotham et al. [22]), and by extension a detrimental role of
reduced medication levels in the observed VF decline after STN-DBS.
But Gotham et al. [22] also reported no signiﬁcant differences within
the PDgroupon (semantic)VFperformance for ONandOFF dopaminer-
gic medication, which, in essence, is the crucial and most sensitive con-
trast in this respect, and thus not suggestive of an effect of dopaminergic
medication on VF performance.
Nonetheless, since changes in dopaminergic medication levels be-
tween baseline and follow-up are often compared to the observed de-
clines in VF after DBS, this allowed the aforementioned meta-analyses
by Parsons et al. [48] and Combs et al. [12] to also test for such a relation.
Neither of them found any relation between reductions in medication
levels and VF decline following DBS. And even though this is in essence
a null result, the combined evidence of the two meta-analyses strongly
suggests that reduced levels of dopaminergic medication (after STN-
DBS) cannot account for the observed VF declines after DBS.
4.3. Electrode Positions
A few studies have investigated the effects of electrode locations on
the observed worsening of VF after DBS. And even though the evidence
is still sparse, this factor seems to affect the VF performance after DBS to
a larger degree than disease progression and reducedmedication levels.
Witt et al. [75] observed a signiﬁcant worsening of semantic VF in a
group of STN-DBS PD patients compared to a PD control group on BMT.
By dividing the STN-DBS group into decliners and stable performers,
they found that the active contacts of 75% (9 out of 12) of the decliners
lay outside the pseudo-volume created on the basis of the active con-
tacts of the 19 stable performers. Especially in the left hemisphere,
most of the decliners' active contacts were also placed more ventrally.
Okun et al. [46], on the other hand, altered the active contact for
stimulation in both unilateral STN-DBS and GPi-DBS patients in order
to test the effects of a more dorsal contact, a more ventral contact, the
optimal contact and OFF stimulation (i.e., four settings in total). They
observed no effects of this manipulation on VF, but they did observe a
decline between baseline and follow-up in phonemic VF in the STN
group across all four settings (which was greater than the GPi group,
but the contrast did not reach their predeﬁned p b 0.025 level of signif-
icance). On the basis of observing the non-signiﬁcant worsening of VF
also in theOFF stimulation condition, the authors suggested an insertion
effect rather than stimulation per se as the cause of this decline. Howev-
er, based on a subset of the STN-DBS patients from the very same cohort,
Okun's group [41] subsequently reported on correlations between vol-
ume of tissue activated (VTA) and phonemic VF decline. Here, stimula-
tion of larger ventral parts of STN was correlated with worse VF
performance [41]. And in a further follow-up study on the GPi-DBS pa-
tients, Okun's group [19] showed that stimulation region did not affect
VF performance in a subset of the GPi-DBS patients [19], who also did
not show any signiﬁcant declines in VF after DBS.Please cite this article as: Højlund A, et al, Worsening of Verbal Fluency Af
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Furthermore, the patients included in COMPARE trial and reported
by Okun et al. [46], as well as by Mikos et al. [41] and Dietz et al. [19],
were all unilaterally implanted with either STN-DBS or GPi-DBS.
Hence, testing stimulation of different contact positions with bilateral
stimulation could potentially have greater effect on VF performance
than those reported by Okun et al. [46].
Ehlen et al. (2014) found that STN-DBS PD patients' changes in VF
performance between ON and OFF stimulation correlated with elec-
trode location and stimulation amplitude. Better VF performance in
ON than OFF was associated with more antero-medial positions and
higher stimulation amplitudes, which suggests at least some active
component in the stimulation itself. We note, however, that this sug-
gested effect of the stimulation itself was beneﬁcial to VF performance,
rather than detrimental. And since the study did not include any base-
line measurements of the patients' VF performance before surgery, it
is difﬁcult to know how these beneﬁcial effects of stimulation were re-
lated to any potential worsening of VF performances compared to pre-
surgery baseline.
Finally, York et al. [83] also found correlations between VF declines
and electrode locations of variable kinds.More superior and lateral loca-
tions in the left hemisphere seemed to be associated with greater pho-
nemic VF declines. In the right hemisphere, greater phonemic VF
declineswere associatedwith electrodes locatedmore posterior and su-
perior, but laterally closer to STN. And greater semantic VF declines
were correlated with more superior locations in the right hemisphere.
These results are not straightforward to interpret as they rely on a mul-
titude of correlations with a relatively small sample size, but they still
suggest associations between electrode locations and the observed VF
declines.
The available evidence on effects of electrode locations on the ob-
served worsening of VF after DBS is still preliminary and inconclusive.
But when detailed VTA-modeling is taken into account as in Mikos
et al. [41], or decliners are compared to stable performers in a volumet-
ric space as inWitt et al. [75], electrode positions do seem to play a role
in VF decline following DBS – in STN, at least.
4.4. Stimulation vs. Surgery
Even though the evidence is not overwhelming, the correlations be-
tween electrode locations and the observed VF declines suggest that ei-
ther the stimulation itself or insertion effects from the surgery may
affect VF performance after DBS in STN. Unfortunately, the sparse liter-
ature on this matter is inconclusive, but it does seem to suggest that
both the stimulation and the surgery itself may have effects on the ob-
served worsening of VF after DBS.
Wojtecki et al. [77] showed that the frequency of stimulation of STN
had opposite effects on motor symptoms and verbal ﬂuency in PD pa-
tients. Low frequency stimulation at 10 Hz improved VF performance
while worsening themotor symptoms compared to the typical high fre-
quency stimulation at 130 Hz, which improved motor symptoms while
worsening VF performance. This suggests an active role of the stimula-
tion frequency, and by extension the stimulation itself, in the VF perfor-
mance of STN-DBS-treated PD patients.
However, in a more recent open label RCT study, Okun et al. [45]
employed a study designwith a delayed DBS activation group as control
group. 25% of the implanted patients were randomly assigned to a con-
trol group where the DBS would not be turned on until 3 months after
surgery. Interestingly, the authors found that both groups showed
worsening of phonemic and semantic VF after 3 months, a worsening
that was sustained after 12 months in both groups. This evidence, on
the other hand, strongly suggests an effect of surgery, rather than
stimulation.
When it comes to testing ON and OFF stimulation effects on VF per-
formance, one study has shown signiﬁcant differences in VF perfor-
mance between ON and OFF stimulation with worse performance
during ON [57], supporting the notion of an active role of theter Deep Brain Stimulation in Parkinson's Disease: A Focused Review,
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stimulation. In contrast to this, as alreadymentionedOkun et al. [46] did
not observe any signiﬁcant differences between ON and OFF stimula-
tion, despite a general VF declinewith STN-DBS after surgery, suggestive
of an insertion effect from surgery rather than the actual stimulation.
And yet the few other studies that have tested ON and OFF stimulation
in relation to VF show mixed results between phonemic and semantic
VF but with incomplete reporting (e.g., lack of baseline, use of test com-
posite scores, lack of tests on the relevant contrasts) due to which we
cannot fully assess the similarity of the observed VF declines or lack
thereof during ON and OFF stimulation [20,28,43,50].
Smith et al. [61] addressed the potential effects of microlesions from
a different angle by using the number of micro-eletrode (MER) passes
during surgery as an index of the extent of the microlesion in STN
from the surgery, and they did not ﬁnd any signiﬁcant correlations be-
tween the number of MER passes and the phonemic VF decline after
DBS.
Common to the few studies reporting no difference in VF perfor-
mance during ON and OFF stimulation – and hence suggesting insertion
effects – is that their evidence is based on negative results. But such null
results do not provide very conclusive evidence since the absence of
evidence is not evidence of absence. Equivalence testing [54,58] or
Bayesian statistics [18,33], on the other hand, provide statistical frame-
works that allow the researcher to interpret such null results in a more
systematic and meaningful manner.
Furthermore, most of the studies testing ON and OFF stimulation ef-
fects only allowed 10–30min before startingneuropsychological testing
after turning OFF the stimulation [46,50,77], or do not report how long
they waited [20,28,43,57]. This is a relatively short interval considering
that the cardinal PD motor symptoms vary between a few minutes and
several hours in how quickly they are alleviated/reappear after turning
ON/OFF the DBS [65]. With a similar design studying response inhibi-
tion, Hershey et al. [26] observed differences between unilateral activa-
tion of a more dorsal and more ventral contact during a Go/NoGo-task
after waiting at least 42 min between change of stimulation settings
and testing. Hence, when employing the ON vs. OFF stimulation design,
or when testing the effect of stimulation in different active contacts, it
may be advisable towait at least 45min [26], and perhaps even 2 h con-
sidering themotor symptoms [65], before testing VF or other neuropsy-
chological measures.
Thus, it is still unclear from the literature to what extent the ob-
served VF declines after DBS are caused by insertion effects from the
surgery or caused by the actual stimulation itself. But nonetheless, stim-
ulation and insertion effects in combinationwith electrode locations are
those of the suggestedmechanisms behind the VF decline that show the
strongest associations with the observed worsening of VF after DBS.
4.5. Patient Inherent Risks for VF Worsening
This focused review deals with the reported VFworsening after DBS,
i.e., in the PD patient cohorts that are screened and found eligible for
DBS and who then receive the treatment. This means that it does not
deal with the potentially increased risks for VF worsening (and other
cognitive declines) in PD patients that are deemed too old or too
cognitively impaired to receive DBS.
Results from two RCT studies [15,60] have suggested that advanced
age, low levodopa response and higher levodopa equivalent dose (LED)
at baseline were associated with cognitive decline after DBS. However,
as noted by Daniels et al. [15], their three factors (higher age, higher
LED and higher axial subscore on UPDRS-III at baseline) only explained
about 23% of the variance in the cognitive decline after DBS. Further-
more, both studies made use of composite scores for their measures of
cognitive decline, and their results are therefore not directly transferra-
ble to the reported VF worsening after DBS, which is of focus in this
review.
And importantly, both the aforementioned meta-analyses of VF
worsening after DBS by Parsons et al. [48] and Combs et al. [12] reportedPlease cite this article as: Højlund A, et al, Worsening of Verbal Fluency Af
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that none of the investigated risk factors were related to VF worsening
after DBS. Parsons et al. [48] tested age, disease duration, stimulation pa-
rameters, and LED change after surgery asmoderators of the VF decline.
Combs et al. [12] tested age, disease duration, LED at baseline, and
UPDRS score off medication at baseline in relation to the reported VF
worsening. Hence, it does not seem that any of the potential patient in-
herent risks in the DBS-treated PD cohorts can account for the observed
VF worsening after surgery.
5. Heterogeneity in Prevalence
As already alluded to, there is considerable heterogeneity in the
prevalence of the worsening of VF after DBS. It seems that a subset of
patients (10–40%) are often driving the reported group effects of VF
decline [7,14,31].
Unfortunately, far from all studies report proper assessments of this
individual variation, e.g., reliable change indices (RCIs; [27,67]), but the
studies that do include RCIs for pre- and post-surgery evaluations all re-
port a small but substantial subgroup of patients with reliable declines,
whereas the rest of the DBS patients experience no reliable difference in
VF or maybe even a slight improvement. Williams et al. [72] reported
that 26% and 29% of STN-DBS PD patients showed reliable declines in
phonemic and semantic VF, respectively. The same numbers for their
GPi-DBS group were 11% and 29%, respectively. Witt et al. [75] reported
that 23% and 39% of STN-DBS PD showed reliable declines in phonemic
and semantic VF. Rothlind et al. [55] reported that, across both groups of
STN- and GPi-DBS, 16.5% and 11% showed reliable declines in phonemic
and semantic VF. And they observed no differences in prevalence be-
tween the two groups. York et al. [82] reported that 26.1% and 40% of
STN-DBS PD showed reliable declines in phonemic and semantic VF. Fi-
nally, Zahodne et al. [84] also referred to an observation of heterogene-
ity in VF declines following unilateral DBS.
To the best of our knowledge, this relatively large degree of individ-
ual variation has not received any thorough and systematic attention.
And yet it seems that what is consistently reported as a group effect, is
mainly driven by a small subgroup of the DBS-treated patients. In our
view, this heterogeneity in prevalence seems to hold promising explan-
atory potential for the worsening of VF after DBS if properly character-
ized and investigated.
6. Possible Underlying Mechanisms
As previouslymentioned, VF involves several cognitive processes re-
lated to linguistic and executive functioning, in particular [24,25,35,59].
By the use of interference tasks, neurocognitivemodels have focused on
contrasting phonemic and semantic VF performance in an attempt to
ascribe them to frontal lobe (executive functioning) and temporal lobe
(lexical search) processes, respectively [39,44].
Lesion studies have reﬁned this proposed dissociation between pho-
nemic and semantic VF. In ameta-analysis onVF performance after focal
cortical lesions, Henry & Crawford [25] showed that frontal lesions af-
fected phonemic and semantic VF to similar extents, whereas temporal
lobe lesions affected semantic VFmore than phonemic VF, suggestive of
a shared frontal lobe component in both phonemic and semantic VF.
Furthermore, Chouiter et al. [10] recently investigated VF performance
in 191 patients with traumatic brain injury (TBI) and managed to also
include patients with brain lesions in subcortical structures. This
allowed them to show that basal ganglia structures, including putamen,
caudate nucleus, and globus pallidus, were integral to both phonemic
and semantic VF, which is in line with the reported effects of DBS in
STN (and GPi) on VF in PD patients.
To add to this, Troyer et al. [66] suggested on the basis of their study
of patients with focal brain lesions that the contributions of frontal-lobe
and temporal-lobe processes were related to switching and clustering,
respectively, both of which are subprocesses of VF and not speciﬁc to
phonemic or semantic VF. Recently, Vonberg et al. [68] analyzed clusterster Deep Brain Stimulation in Parkinson's Disease: A Focused Review,
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and switches during VF performance with DBS ON and OFF. Here, they
showed more switches (and marginally shorter switch times) during
DBS ON compared to DBS OFF, but with no signiﬁcant differences in
the total number of words between ON and OFF. The authors interpret
these results to suggest that STN-DBS may subtly increase cognitive
ﬂexibility in PD patients. However, due to no baseline evaluations it is
difﬁcult to fully assess the role of the increased number of switches in
relation to potential worsening of VF after DBS. Further supporting our
observation of considerable heterogeneity in the prevalence of VFwors-
ening, the authors' inclusion of data on the individual patients' VF per-
formances in the supplementary material conﬁrmed substantial
individual differences in the degree to which patients performed better
or worse during DBS ON or OFF.
Very tentatively, the limited evidence from the literature seems to
suggest that STN (and GPi) may be involved in VF performance through
a basal-ganglia-thalamocortical network [29,64] involving mainly dor-
solateral prefrontal cortex (dlPFC, BA 9, 46) and left inferior frontal
gyrus (l-IFG, BA 44–45) at the cortical level as is suggested by the few
available PET studies on VF in DBS-treated PD patients [31,57]. This
subthalamo-frontocortical connection is further supported by a recently
published study by Wojtecki et al. [76] combining recordings of local
ﬁeld potentials (LFP) in the STN through externalized DBS electrodes
and EEG scalp recordings. Preliminary results from ﬁve PD patients
demonstrated enhanced coherence between STN and frontal cortex in
the low-frequency bands (alpha-theta, 5–15 Hz) during a verbal gener-
ation task [76].
7. Directions for Future Research
Crucially missing from this present overview is more evidence on
the effects of stimulation itself and surgery on the reported VF worsen-
ing after DBS, as well as on the effects of electrode locations. These as-
pects entail comparing VF performance during both ON and OFF
stimulation conditions at follow-up compared to baseline, as well as re-
lating the potential worsening to detailed VTA-modeling in the individ-
ual patients. A few studies have already employed ON/OFF testing
including baseline measurements, but this holds for only one of the
RCT studies [46]. The total number of such studies does not warrant a
meta-analysis as of yet. Hence further studies implementing this study
design are needed. And in this regard, more studies making use of the
design introduced by Okun et al. [45] with a delayed DBS activation
group would allow for further assessments of the potential chronic ef-
fects of stimulation which cannot be assessed with an ON/OFF design
with relatively short OFF periods (minutes or a few hours).
Furthermore, only very few studies have tested the effects of stimu-
lation while patients were also OFF medication, which is the most opti-
mal way to directly target an actual stimulation effect. Finally, evidence
from such study protocols in terms of ‘no signiﬁcant differences’ be-
tween the two conditions is not sufﬁcient in this regard. Equivalence
testing or Bayesian inference should be used to address and interpret
such potential null results more meaningfully.
Regarding the heterogeneity of the prevalence of VF declines among
DBS-treated PD patients, this has not received sufﬁcient attention, why
we recommend this aspect to be taken into account in future studies, es-
pecially in combination with more detailed VTA-modeling. In this re-
gard, it may not be sufﬁcient to merely compare stimulation in
“dorsal” and “ventral” contacts (as in [46]) in order to account for the
potential effects of electrode location and stimulation. Anatomical
considerations concerning both cortical projections (the hyperdirect
pathway from frontal cortex) and subcortical basal ganglia (BG) con-
nections to and from the ventro-medial part of STN (referred to as the
‘associative’ subregion) would be of great value in this context. The tra-
ditional view of STN anatomy and function divides it into three separate
regions, themotor, associative and limbic regions [37]. However, recent
primate studies using anterograde tracers suggests noticeable overlaps
between these three subsections [4,23] in addition to a high degreePlease cite this article as: Højlund A, et al, Worsening of Verbal Fluency Af
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of variation in the overall size and position of the STN in PD patients
[16,52].
Recent methodological advances in both acquisition and processing
of diffusion-weighted MRI (DWI) allow us to non-invasively map the
structural networks of the brain with a newfound precision [30,62].
Such diffusion-based tractography has already been used to examine
the tissue and pathways targeted in DBS treatment [6,49]. These ad-
vanced techniques allow for detailed delineation of the connections be-
tween the STN (and GPi), cortex and other BG structures at the
individual patient level. Several studies in healthy adults have demon-
strated how the STN subsections and overlaps can be delineated using
tractography [1,2,34,51]. Implementing state-of-the-art tractography
methods, combined with VTA-modeling, may allow detailed explora-
tion of the neural pathways stimulated with DBS in individual patients.
Further integrating these methodological advances with measures of
behavior and neurophysiology (such as VF performance and M/EEG re-
cordings) provides a clear avenue for advancing our knowledge of the
mechanisms of DBS and its potential role in the observed worsening
of VF after DBS.
In relation to potentially mapping the neural pathways stimulated
with DBS in the individual patient, the few functional neuroimaging
studies on VF and DBS in PD using PET [31,57] have shown correlations
between reduced activity in left inferior frontal gyrus (IFG) and (left)
dorsolateral prefrontal cortex (dlPFC) and worsening of VF as an effect
of STN-DBS. The sparse neuroimaging evidence thus supports a more
active role of the stimulation itself in the VF decline where STN-DBS
may affect this frontal network through its indirect connections to thal-
amus via GPi [3,47,64], or antidromically via the hyperdirect pathway
connecting the prefrontal cortex directly to STN [29]. The observed
worsening of VF after GPi-DBS could potentially be attributed to similar
network via thalamus, but more studies are still needed in order to as-
sess how reliably VF is negatively affected by DBS in GPi.8. Conclusion
Based on recent and earlier meta-analyses, there is reliable evidence
for a worsening of both phonemic and semantic VF after DBS. This pri-
marily pertains to STN-DBS since the number of available studies on
the cognitive sequelae of GPi-DBS is still too low for drawing reliable
conclusions. The effect sizes of the VF worsening are moderate in size,
which seems to be tolerable at the group level, but these tolerable effect
sizes may also be reﬂective of more debilitating effects in a subgroup of
PD patients with DBS.
There is no clear impression of the possible underlying mechanisms
from the literature, but with evidence from PD control groups on best
medical treatment (BMT) in two large-scale RCT studies, disease pro-
gression does not seem to be able to account for the worsening of VF
in DBS patients. Also, DBS-related reductions in dopaminergic medica-
tion (mainly in STN-DBS patients) cannot account for the VF decline.
Hence, it seems that either surgery or stimulation itself or both to-
gether in combination with the electrode positions are driving factors.
However, the evidence in this relation is inconclusive and sparse. The
few studies that include detailed VTA-modeling seem to suggest an ac-
tive role of the stimulation, at least in STN-DBS. But at the same time, the
few studies testing VF performance during ON and OFF stimulation
failed to ﬁnd signiﬁcant differences between the two conditions, tenta-
tively suggestive of an insertion effect from the surgery, rather than
stimulation itself. Hence, more studies are needed before a systematic
meta-analysis can be conducted.
Finally, we have highlighted an aspect of the literature that has not
received systematic attention to date, namely a large degree of hetero-
geneity in the incidence of VF declines following DBS (in both STN and
GPi). We speculate that individual variation in cortical and subcortical
connections to and from STN and/or GPi may contribute to this
heterogeneity. Hence, the application of advanced tractography inter Deep Brain Stimulation in Parkinson's Disease: A Focused Review,
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into the role of stimulation effects vs. effects of surgery.
Our recommendations for future studies on VF include optimizing
study designs to include both ON and OFF stimulation as well as
baseline measures, calculating reliable change indices (RCI) for neuro-
psychological results, and acquiring diffusion-weightedMRI on patients
for tractography of cortical and subcortical connections to and from
STN/GPi.T
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